Crown Bioscience Recognized for ADC Innovation in 2026 BioTech Breakthrough Awards
SAN DIEGO — November 6, 2026 — Crown Bioscience, a global contract research organization (CRO) specializing in oncology drug discovery and development…
Read moreSAN DIEGO—November 16, 2026 — Crown Bioscience today confirmed that JSR Corporation and Miramar Lifesciences Limited, a wholly owned subsidiary of Adicon Holdings Limited, have mutually agreed to terminate the share transfer agreement announced in November 2025, effective November 13, 2026.
This decision was reached because the conditions required for closing were not expected to be satisfied within the originally anticipated timeframe.
There will be no changes to Crown Bioscience’s business operations or relationships with customers and partners as a result of this decision.
For further information, please refer to JSR Corporation's official announcement.
Media Inquiries:
Crown Bioscience
Sarah Martin-Tyrrell
Crown Bioscience, (2026) Update on Proposed Acquisition of Crown Bioscience - Crown Bioscience. https://www.crownbio.com/about-us/news-and-events/update-on-proposed-acquisition-of-crown-bioscience
SAN DIEGO — November 6, 2026 — Crown Bioscience, a global contract research organization (CRO) specializing in oncology drug discovery and development…
Read moreSAN DIEGO—November 2, 2026 — Crown Bioscience, a global contract research organization (CRO) specializing in oncology drug discovery and development, …
Read moreNew standalone platform harmonizes global HR processes, strengthen operational scalability, and create a more consistent employee experience.
Read more